SCHEMBL14488993

SCHEMBL14488993

CCc1nnc(C(=O)[C@H](CC)NC(=O)[C@H](CS(=O)(=O)Cc2ccccc2)NC(=O)N2CCOCC2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 13/20 0.51
CTSB P07858 6/20 0.41
CTSL P07711 6/20 0.41
CTSK P43235 2/20 0.41
CTSH P09668 1/20 0.41
CTSC P53634 1/20 0.41
PSMB11 A5LHX3 1/20 0.37
PSMA7 O14818 1/20 0.37
PSMB1 P20618 1/20 0.37
PSMA1 P25786 1/20 0.37
PSMA2 P25787 1/20 0.37
PSMA3 P25788 1/20 0.37
PSMA4 P25789 1/20 0.37
PSMB8 P28062 1/20 0.37
PSMB9 P28065 1/20 0.37
PSMA5 P28066 1/20 0.37
PSMB4 P28070 1/20 0.37
PSMB6 P28072 1/20 0.37
PSMB5 P28074 1/20 0.37
PSMB10 P40306 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636267 1.00 CTSS (0.51) CTSSCTSBCTSLCTSKCTSH
SCHEMBL14427114 0.89 CTSS (0.52) CTSSCTSBCTSLCTSKCTSH
SCHEMBL6630641 0.89 CTSS (0.52) CTSSCTSBCTSLCTSKCTSH
SCHEMBL14427108 0.85 CTSS (0.51) CTSSCTSBCTSLCTSKCTSH
SCHEMBL7043174 0.85 CTSS (0.51) CTSS
SCHEMBL14427112 0.85 CTSS (0.51) CTSSCTSBCTSLCTSKCTSH
SCHEMBL14427076 0.83 CTSS (0.53) CTSSCTSBCTSLCTSKCTSH
SCHEMBL14427088 0.83 CTSS (0.53) CTSSCTSBCTSLCTSKCTSH
SCHEMBL14562966 0.81 CTSS (0.39) CTSSCTSBCTSLCTSK
SCHEMBL5424808 0.81 CTSS (0.39) CTSSCTSBCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7226921-B2 Compounds and compositions as cathepsin S inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2007-06-05 US disclosed
US-7226921-B2 Compounds and compositions as cathepsin S inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2007-06-05 US disclosed